CENTRE DE CANCEROLOGIE DU GRAND MONTPELLIER

What CENTRE DE CANCEROLOGIE DU GRAND MONTPELLIER does

The Centre de Cancérologie du Grand Montpellier (CCGM) is a private cancer treatment center located within Clinique Clémentville in Montpellier, France. The center was formed from the merger of radiotherapy services previously operated by Clinique Clémentville and Clinique Saint Roch, and today operates as the principal liberal radiotherapy and oncology facility in the Montpellier area. CCGM provides a comprehensive cancer care pathway including external beam radiotherapy, ambulatory chemotherapy, permanent prostate brachytherapy using iodine-125 seeds, and an extensive supportive care program covering pain management, psycho-oncology, social work, palliative care, and wellness workshops such as shiatsu, sophrology, music therapy, and cooking classes. The center treats adult cancer patients across all tumor localizations — breast, lung, digestive, urological, gynecological, brain, and head-and-neck — with patient acquisition primarily driven by physician referrals and the Doctolib online booking platform.

CCGM's technology base includes four linear accelerators: two VARIAN Halcyon systems (installed November 2020 and April 2024), a CyberKnife stereotactic system, and a CLINAC 2100C/D with 120-leaf multileaf collimator. The CyberKnife is described as the only facility of its kind in the entire Occitanie region, providing sub-millimetric robotic stereotactic radiotherapy for small to medium tumors in brain, bone, lungs, liver, pancreas, adrenals, and benign lesions. The center operates extended treatment hours (7:30 to 19:50, Monday through Friday), runs a centralized cytotoxic chemotherapy reconstitution unit, and maintains an active clinical research program with open enrollment trials in breast, lung, and digestive cancers. Patient access is supported by a network of eight satellite consultation locations across the Greater Montpellier area and wider Hérault and Aveyron departments.

CCGM's revenue model is fully integrated within the French national health insurance framework (Sécurité sociale / CPAM). As a private healthcare facility, it generates revenue through standard reimbursement for radiotherapy, chemotherapy, brachytherapy, and supportive care services, with cancer treatments classified as ALD (Affections de Longue Durée) covered at 100% by national health insurance. The center explicitly states that it does not practice fee overruns (dépassements d'honoraires), eliminating patient cost as a barrier while also capping per-session reimbursement upside. The organization is led by Director Maxime SIKLI, with medical research direction by Dr Cristian VILLANUEVA, and is institutionally networked into the Institut de Cancérologie Privé, Onco Occitanie, and the Montpellier Institut du Sein (Le MIS).

Name

CENTRE DE CANCEROLOGIE DU GRAND MONTPELLIER

Legal name

Centre de Cancérologie du Grand Montpellier

Website

https://ccgm.fr

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The Centre de Cancérologie du Grand Montpellier (CCGM) is a private cancer treatment center in Montpellier, France. It provides radiotherapy, chemotherapy, brachytherapy, and supportive care to adult cancer patients across the Occitanie region, operating four linear accelerators including the region's only CyberKnife.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Ambulatory Health Care Services (621)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Oncology Telemedicine Platforms (HLALAGAH)

Keywords

• Radiation therapy services
• Oncology treatment center
• Stereotactic radiotherapy
• Brachytherapy services
• Supportive cancer care

Headquarters

HQ city

Montpellier

HQ country

France

HQ region

Europe

Offices9 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Others

Revenue model

1. Radiotherapy and oncology treatment reimbursement: As a French private healthcare facility, CCGM generates revenue through the French national health insurance system (Sécurité sociale / CPAM). Cancer treatments classified as ALD (Affections de Longue Durée) are covered at 100% by national health insurance. The center states it does not practice fee overruns (dépassements d'honoraires), meaning all care is billed within the public reimbursement framework. Additional revenue streams include consultations, chemotherapy administration, brachytherapy, and supportive care services.
2. Transport and administrative fees: Transport costs between home and the center are reimbursed by the national health insurance when prescribed by a physician, subject to standard CPAM rules (entente préalable for journeys over 150km). Revenue from ancillary services including administrative processing.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

The Centre de Cancérologie du Grand Montpellier (CCGM) is a private liberal radiation therapy and oncology center formed from the merger of radiotherapy services of Clinique Clémentville and Clinique Saint Roch. It provides a fully integrated cancer care pathway including external beam radiotherapy (Halcyon, CyberKnife, CLINAC accelerators), ambulatory chemotherapy, prostate brachytherapy (permanent iodine-125 seed implantation), and multidisciplinary supportive care services for adult oncology patients.

Product overview

CENTRE DE CANCEROLOGIE DU GRAND MONTPELLIER (CCGM) is a private oncology and radiotherapy center resulting from the fusion of radiotherapy services from Clinique Clémentville and Clinique Saint Roch. It offers a comprehensive, integrated cancer care pathway within a specialized pole. The center provides radiotherapy services (using Halcyon, CyberKnife, and CLINAC accelerators), chemotherapy (chimiothérapie ambulatoire), prostate curietherapy (permanent iodine-125 brachytherapy), and supportive care services. The center also conducts clinical research and offers patient support programs including psychological support, nutritional counseling, pain management, social work assistance, and wellness workshops such as sophrology, shiatsu massage, musicotherapy, and cooking classes.

Differentiator

Problem solved

Functional benefit

Products and services

• Radiotherapy Services (Halcyon Linear Accelerators) External beam radiotherapy delivered on VARIAN's latest-generation Halcyon accelerators (two units installed in November 2020 and April 2024), featuring ultra-fast CBCT imaging for millimetric repositioning, silent operation, and reduced treatment times; available to adult cancer patients referred for radiotherapy across multiple tumor types.
• CyberKnife Stereotactic Body Radiotherapy (SBRT) Stereotactic radiotherapy using a robotic CyberKnife linear accelerator unique in Occitanie; delivers sub-millimetric precision via an articulated mobile robot with real-time imaging tracking, treating small to medium tumors in brain, bone, lungs, liver, pancreas, adrenals, and benign tumors (meningiomas, neuromas) without invasive restraint systems.
• CLINAC 2100C/D Radiotherapy External beam radiotherapy using the CLINAC 2100C/D 120-leaf accelerator installed in 2015, dedicated to dynamic modulated intensity arc therapy (IMRT) with automatic onboard imaging-based patient repositioning, also capable of stereotactic treatment of small lesions.
• Ambulatory Chemotherapy (Chimiothérapie) Ambulatory chemotherapy day hospital service covering drug preparation in a centralized cytotoxic reconstitution unit, administration of cytotoxic products, pre-medication, blood test validation, and follow-up; protocols include chemotherapy, targeted therapies, and immunotherapy for adult oncology patients.
• Prostate Brachytherapy (Curiethérapie de prostate) Permanent brachytherapy for prostate cancer using iodine-125 radioactive seeds implanted under general anesthesia with 48-hour hospitalization; performed jointly by a urologist and radiation therapist with real-time ultrasound-based dosimetry.
• Comprehensive Supportive Care (Soins de support) Integrated supportive care program including pain management, dietary support, psychological oncology (psycho-oncology), social work, palliative care, socio-aesthetics, and rehabilitation/physiotherapy — coordinated as part of an interdisciplinary cancer care approach for patients and families.
• Clinical Research Program (Recherche clinique) Clinical research program offering patients access to innovative treatments through academic and industry-sponsored studies in oncology, evaluating new therapeutic molecules, radiotherapy and surgical techniques, and supportive care developments — including ongoing trials in breast cancer (ELEVATE, TROFUSE 032, OPERA-01, INAVO 123, Fourlight-3, REPARP, PionERA, MK2870-010, ELECTRA, DYNASTY Breast 02), digestive cancers, and lung cancers.

Quantifiable outcome

• Treatment hours available from 7:30 to 19:50, Monday to Friday — extended daily operating window maximizing patient throughput

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

Eleven partnerships are on record, tiered minor, core and major.

• MHR Solidaire (Montpellier Hérault Rugby Solidarity)minorGTM or Marketing Partner · 1 January 2025CCGM partners with MHR Solidaire for the Rugby Santé program — a touch rugby program adapted for cancer patients and survivors. Sessions are held weekly at MHR facilities, promoting physical activity as part of cancer survivorship care. This community health partnership raises awareness and visibility of CCGM within the local community.
• OC SantécoreStrategic or Co-development PartnerOC Santé is a regional private healthcare group with which CCGM is affiliated. The center is hosted within Clinique Clémentville, which is part of the OC Santé network. This partnership provides access to shared diagnostic infrastructure (medical imaging, biology, nuclear medicine) and institutional coordination across the private healthcare sector in Occitanie.
• Institut de Cancérologie PrivécoreStrategic or Co-development PartnerCCGM is linked with the Institut de Cancérologie Privé (ICP), sharing resources, clinical expertise, and research programs. The partnership supports multidisciplinary care coordination and clinical research activities.
• Onco OccitaniemajorStrategic or Co-development PartnerOnco Occitanie is a regional oncology network that coordinates cancer care across the Occitanie region. CCGM participates in this network to ensure care coordination, knowledge sharing, and adherence to regional oncology protocols.
• Montpellier Institut du Sein (Le MIS)majorStrategic or Co-development PartnerA specialized breast cancer institute in Montpellier with which CCGM collaborates for integrated breast cancer care pathways. Patients can be referred between CCGM's radiotherapy/oncology services and the breast cancer institute for multidisciplinary management.
• Institut EquiphoriaminorGTM or Marketing PartnerCCGM refers patients to Equiphoria, a center in Lozère offering hippotherapy (horse-assisted therapy) as part of cancer recovery. The program consists of 5 personalized sessions over 5 consecutive days. CCGM promotes this program to its patients as part of its survivorship and supportive care offerings. Financial coverage of 80–100% is available through social protection groups.
• MIDIPERF SANTÉminorStrategic or Co-development PartnerCCGM collaborates with MIDIPERF SANTÉ, a home healthcare provider, for a roundtable on home artificial nutrition. This partnership supports at-home care continuity for cancer patients requiring nutritional support.
• Clinic ClémentvillecoreStrategic or Co-development PartnerCCGM operates within and is hosted by Clinique Clémentville, sharing facilities, diagnostic services (medical imaging, laboratory, nuclear medicine), and clinical staff. This is the founding institutional partnership from which the center emerged.
• Association Les ChrysalidesminorGTM or Marketing PartnerPartnership with Association Les Chrysalides for socio-aesthetic care (free well-being treatments for patients) and free legal consultation services for patients. The association provides volunteer socio-aestheticians and organizes a legal clinic in partnership with Féminin Pluriel Montpellier Méditerranée.
• Association ASP Montpellier HéraultminorGTM or Marketing PartnerASP Montpellier Hérault provides trained volunteer companions who visit the day hospitalization service (chemotherapy room) to offer emotional support and presence to patients during treatment, complementing the clinical team.
• Association JALMAV-MontpellierminorGTM or Marketing PartnerJALMAV-Montpellier provides trained volunteer companions who visit the medicine ward (1st floor) to offer emotional support and presence to inpatients, complementing the clinical team.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• OC Santé: Regional private healthcare group that hosts CCGM at Clinique Clémentville and operates other clinics in Occitanie. Functions as a broader incumbent providing shared infrastructure, imaging, and institutional coordination.
• Institut Curie: Paris-based historic cancer center combining a hospital and research center, operating an integrated radiotherapy, brachytherapy and chemotherapy pathway — a broad national incumbent comparable on service model and clinical research.
• Institut Gustave Roussy: France's leading comprehensive cancer center and Europe's largest, offering the full oncology pathway (radiotherapy including SBRT, chemo, brachytherapy, trials) — a broad incumbent benchmark for technology and clinical research scope.

Regional players

• Centre Léon Bérard: Lyon-based UNICANCER comprehensive cancer center offering similar integrated radiotherapy, chemotherapy, brachytherapy and supportive care services — comparable regional French peer outside Occitanie.
• Centre Oscar Lambret: UNICANCER comprehensive cancer center in Lille operating a comparable private-public hybrid model offering radiotherapy, brachytherapy, chemotherapy and supportive care — comparable in service mix though in northern France.
• Institut Paoli-Calmettes: Marseille-based UNICANCER comprehensive cancer center serving the Provence-Alpes-Côte d'Azur region with a comparable integrated cancer care offering across radiotherapy, medical oncology, brachytherapy and clinical research.

Others

• Onco Occitanie: Regional oncology coordination network across the Occitanie region that includes CCGM as a member. Functions as an ecosystem peer rather than direct competitor, setting regional protocols and care pathways.
• Clinique Clémentville: Host private clinic under OC Santé where CCGM is physically located. While not a direct oncology competitor, it shares infrastructure, imaging and inpatient beds and is a critical operational partner/landlord.

Direct peers

• Institut du Cancer de Montpellier (ICM): Major public/UNICANCER comprehensive cancer center in Montpellier directly competing for the same patient catchment in radiotherapy, medical oncology and clinical trials across Occitanie.
• Institut de Cancérologie Privé (ICP): Affiliated private oncology network in Montpellier that shares resources, clinical expertise, and research programs with CCGM. Operates as a regional peer in the same Occitanie private oncology market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/ICP_Cancer
• Facebookfacebook.com/Mieux-vivre-avec-mon-cancer-Clinique-Cl%C3%A9mentville-115411493229183
• LinkedInlinkedin.com/company/centre-de-cancerologie-du-grand-montpellier

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CENTRE DE CANCEROLOGIE DU GRAND MONTPELLIER